GALNT9 Antibody, FITC conjugated

Size

100ug

Clone Number

Aliases

GalNAc T9 antibody; GalNAc transferase 9 antibody; GalNAc-T9 antibody; GALNT9 antibody; GALT9_HUMAN antibody; Polypeptide GalNAc transferase 9 antibody; Polypeptide N acetylgalactosaminyltransferase 9 antibody; Polypeptide N-acetylgalactosaminyltransferase 9 antibody; pp GaNTase 9 antibody; pp-GaNTase 9 antibody; Protein UDP acetylgalactosaminyltransferase 9 antibody; Protein-UDP acetylgalactosaminyltransferase 9 antibody; UDP GalNAc polypeptide N acetylgalactosaminyltransferase 9 antibody; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9 antibody; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) antibody

Immunogen Species

Homo sapiens (Human)

UniProt ID

Q9HCQ5

Immunogen

Recombinant Human Polypeptide N-acetylgalactosaminyltransferase 9 protein (184-338AA)

Raised in

Rabbit

Species Reactivity

Human

Tested Applications

Background

Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Does not glycosylate apomucin or SDC3.

Clonality

Polyclonal

Isotype

IgG

Purification Method

>95%, Protein G purified

Conjugate

FITC

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Stroage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names

GALNT9

Research Areas

Cancer;Metabolism;Signal transduction